These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 11832530

  • 1. Expression of p53 and prognosis in children with malignant gliomas.
    Pollack IF, Finkelstein SD, Woods J, Burnham J, Holmes EJ, Hamilton RL, Yates AJ, Boyett JM, Finlay JL, Sposto R, Children's Cancer Group.
    N Engl J Med; 2002 Feb 07; 346(6):420-7. PubMed ID: 11832530
    [Abstract] [Full Text] [Related]

  • 2. The relationship between TP53 mutations and overexpression of p53 and prognosis in malignant gliomas of childhood.
    Pollack IF, Hamilton RL, Finkelstein SD, Campbell JW, Martinez AJ, Sherwin RN, Bozik ME, Gollin SM.
    Cancer Res; 1997 Jan 15; 57(2):304-9. PubMed ID: 9000573
    [Abstract] [Full Text] [Related]

  • 3. Age and TP53 mutation frequency in childhood malignant gliomas: results in a multi-institutional cohort.
    Pollack IF, Finkelstein SD, Burnham J, Holmes EJ, Hamilton RL, Yates AJ, Finlay JL, Sposto R, Children's Cancer Group.
    Cancer Res; 2001 Oct 15; 61(20):7404-7. PubMed ID: 11606370
    [Abstract] [Full Text] [Related]

  • 4. Alterations of the TP53 gene in human gliomas.
    Rasheed BK, McLendon RE, Herndon JE, Friedman HS, Friedman AH, Bigner DD, Bigner SH.
    Cancer Res; 1994 Mar 01; 54(5):1324-30. PubMed ID: 8118823
    [Abstract] [Full Text] [Related]

  • 5. O6-methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 Cohort.
    Pollack IF, Hamilton RL, Sobol RW, Burnham J, Yates AJ, Holmes EJ, Zhou T, Finlay JL.
    J Clin Oncol; 2006 Jul 20; 24(21):3431-7. PubMed ID: 16849758
    [Abstract] [Full Text] [Related]

  • 6. Prognostic impact of TP53 mutation status for adult patients with supratentorial World Health Organization Grade II astrocytoma or oligoastrocytoma: a long-term analysis.
    Ständer M, Peraud A, Leroch B, Kreth FW.
    Cancer; 2004 Sep 01; 101(5):1028-35. PubMed ID: 15329912
    [Abstract] [Full Text] [Related]

  • 7. Ethnicity delineates different genetic pathways in malignant glioma.
    Chen P, Aldape K, Wiencke JK, Kelsey KT, Miike R, Davis RL, Liu J, Kesler-Diaz A, Takahashi M, Wrensch M.
    Cancer Res; 2001 May 15; 61(10):3949-54. PubMed ID: 11358811
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Epidermal growth factor receptor expression and gene amplification in high-grade non-brainstem gliomas of childhood.
    Bredel M, Pollack IF, Hamilton RL, James CD.
    Clin Cancer Res; 1999 Jul 15; 5(7):1786-92. PubMed ID: 10430083
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prognostic impact of TP53 mutations and P53 protein overexpression in supratentorial WHO grade II astrocytomas and oligoastrocytomas.
    Peraud A, Kreth FW, Wiestler OD, Kleihues P, Reulen HJ.
    Clin Cancer Res; 2002 May 15; 8(5):1117-24. PubMed ID: 12006527
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Outcome of children with centrally reviewed low-grade gliomas treated with chemotherapy with or without radiotherapy on Children's Cancer Group high-grade glioma study CCG-945.
    Fouladi M, Hunt DL, Pollack IF, Dueckers G, Burger PC, Becker LE, Yates AJ, Gilles FH, Davis RL, Boyett JM, Finlay JL.
    Cancer; 2003 Sep 15; 98(6):1243-52. PubMed ID: 12973849
    [Abstract] [Full Text] [Related]

  • 15. Comparative assessment of the functional p53 status in glioma cells.
    Kim EL, Yoshizato K, Kluwe L, Meissner H, Warnecke G, Zapf S, Westphal M, Deppert W, Giese A.
    Anticancer Res; 2005 Sep 15; 25(1A):213-24. PubMed ID: 15816541
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. p53 protein expression and gene analysis in clear cell adenocarcinoma of the vagina and cervix.
    Waggoner SE, Anderson SM, Luce MC, Takahashi H, Boyd J.
    Gynecol Oncol; 1996 Mar 15; 60(3):339-44. PubMed ID: 8774636
    [Abstract] [Full Text] [Related]

  • 20. p53 mutations in epithelial ovarian cancers: possible role in predicting chemoresistance.
    Laframboise S, Chapman W, McLaughlin J, Andrulis IL.
    Cancer J; 2000 Mar 15; 6(5):302-8. PubMed ID: 11079169
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.